Fig. 2From: Confounding Effects of Benign Lung Diseases on Non-Small Cell Lung Cancer Serum Biomarker DiscoveryIdentification of complement C3f fragments. A SELDI chip was analaysed in a ProTOF200 MALDI to obtain acurate monoisotopic masses (top spectrum). Following purification, the peptides were identified by LC–MS/MS (middle and bottom spectra)Back to article page